Among them, increased eIF3a expression were observed in 21 types of tumors, which included acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) (Fig. 7A, P < 0.05). This evidence concerns the gene EIF3A and acute myeloid leukemia.